SORLA: the protein that slows neuronal collapse in Alzheimer's

Upregulating SORLA, a protein component of the endosomal retromer complex, attenuates the pathological effects of tau in aged PS19 tauopathy mouse brains, according to newly published research. The finding is significant because while SORLA's role in reducing amyloid-β levels was already well understood, its capacity to modulate tau pathology in vivo remained unexplored. Researchers showed that increased SORLA expression reduces tau phosphorylation and seeding, prevents ventricular dilation, limits synaptic loss, restores long-term potentiation, and suppresses glial hyperactivation—the hallmark markers of cognitive decline in Alzheimer's disease. This discovery repositions SORLA as an integral neuroprotective factor against tau toxicity rather than merely an amyloid modulator, and suggests that future therapeutic strategies should focus on activating this compensatory mechanism that the brain already possesses but which becomes compromised during disease progression.